Evolus (EOLS) Other Non-Current Assets (2017 - 2026)

Evolus (EOLS) posted Other Non-Current Assets of $1.6 million for Q1 2026, up 37.45% on a QoQ basis from $1.2 million in Q4 2025, and up 83.11% year-over-year from $900000.0 in Q1 2025.

Evolus (EOLS) Other Non-Current Assets (2017 - 2026) Analysis & Trends

Evolus' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 83.11% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 83.11% YoY) and the FY2025 annual result came in at $1.2 million, up 39.74% from the prior year.
  • Other Non-Current Assets was $1.6 million for Q1 2026 at Evolus, up from $1.2 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.8 million in Q4 2022 and bottomed at $222000.0 in Q3 2023.
  • A 5-year average of $1.4 million and a median of $1.2 million in 2025 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 1005.83% — and 2023, when it tumbled 91.25%.
  • Evolus' Other Non-Current Assets stood at $2.8 million in 2022, then slumped by 85.46% to $409000.0 in 2023, then jumped by 109.78% to $858000.0 in 2024, then surged by 39.74% to $1.2 million in 2025, then surged by 37.45% to $1.6 million in 2026.
  • Business Quant data shows EOLS's Other Non-Current Assets at $1.6 million in Q1 2026, $1.2 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn 1.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.65 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.58 Mn
Jun 30, 2025 1.80 Mn
Mar 31, 2025 900,000.00
Dec 31, 2024 858,000.00
Sep 30, 2024 858,000.00
Jun 30, 2024 409,000.00
Mar 31, 2024 409,000.00
Dec 31, 2023 409,000.00
Sep 30, 2023 222,000.00
Jun 30, 2023 223,000.00
Mar 31, 2023 2.68 Mn
Dec 31, 2022 2.81 Mn
Sep 30, 2022 2.43 Mn
Jun 30, 2022 2.55 Mn
Mar 31, 2022 2.65 Mn
Dec 31, 2021 2.76 Mn
Sep 30, 2021 240,000.00
Jun 30, 2021 240,000.00